DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mesna (Mesna) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (14)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mesna where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mesna side effects in 17 year old female

Reported by a consumer/non-health professional from Denmark on 2012-04-24

Patient: 17 year old female

Reactions: Back Pain, Intervertebral Disc Protrusion, Lymphadenopathy, Pain in Extremity, Osteonecrosis, Fatigue, Pertussis, Arthralgia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Etoposide
    Dosage: 180 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-09

Mesna
    Dosage: 200 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Mesna
    Dosage: 230 mg, unk
    Start date: 2006-09-25
    End date: 2006-10-03

Cyclophosphamide
    Dosage: 775 mg, unk
    Start date: 2006-09-25
    End date: 2006-10-03

Prednisone
    Dosage: 35 + 25 + 25 mg
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-07-03

Prednisone
    Dosage: 20 mg, 3x/day
    Administration route: Oral
    Start date: 2006-07-03
    End date: 2006-08-28

Prednisone
    Dosage: unk
    Administration route: Oral
    End date: 2006-10-10

Procarbazine Hydrochloride
    Dosage: 50 mg three times daily
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-10

Oncovin
    Dosage: 2 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-03

Adriamycin PFS
    Dosage: 57.5mg
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-19

Other drugs received by patient: Potassium Chloride; Glucose ^sad^; Natriumfluorid ^aco Lakemedel^



Possible Mesna side effects in female

Reported by a lawyer from Denmark on 2012-04-06

Patient: female

Reactions: Intervertebral Disc Protrusion, Back Pain, Lymphadenopathy, Bone Pain, Osteonecrosis, Fatigue, Arthralgia, Pertussis

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-09-04
    End date: 2006-09-04

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-09-25
    End date: 2006-09-25

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-07-31
    End date: 2006-07-31

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-07-03
    End date: 2006-07-03

Prednisone TAB
    Dosage: 08maj2006-03jul2006: 35+25+25 mg. 03jul2006-28aug2006: 20 mg x 3.
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-10

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-06-05
    End date: 2006-06-05

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-05-15
    End date: 2006-05-15

Doxorubicin HCL
    Indication: Hodgkin's Disease
    Start date: 2006-06-19
    End date: 2006-06-19

Doxorubicin HCL
    Start date: 2006-05-22
    End date: 2006-05-22

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-07-31
    End date: 2006-07-31

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-08-07
    End date: 2006-08-07

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-07-31
    End date: 2006-07-31

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-05-08
    End date: 2006-05-08

Etoposide
    Start date: 2006-05-08
    End date: 2006-05-12

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-08-28
    End date: 2006-08-28

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-08-28
    End date: 2006-08-28

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-07-10
    End date: 2006-07-10

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-09-04
    End date: 2006-09-04

Vincristine Sulfate
    Dosage: bolus injektion.
    Indication: Hodgkin's Disease
    Start date: 2006-10-03
    End date: 2006-10-03

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-09-11
    End date: 2006-09-11

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-06-19
    End date: 2006-06-19

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-06-12
    End date: 2006-06-12

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-05-22
    End date: 2006-05-22

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Indication: Hodgkin's Disease
    Start date: 2006-10-03
    End date: 2006-10-03

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Indication: Hodgkin's Disease
    Start date: 2006-10-03
    End date: 2006-10-03

Prednisone TAB
    Dosage: 20mgx3
    Administration route: Oral
    Start date: 2006-07-03
    End date: 2006-08-28

Procarbazine Hydrochloride
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-10

Doxorubicin HCL
    Start date: 2006-05-08
    End date: 2006-05-08

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-09-25
    End date: 2006-09-25

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-07-10
    End date: 2006-07-10

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-07-03
    End date: 2006-07-03

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-08-07
    End date: 2006-08-07

Doxorubicin HCL
    Start date: 2006-06-05
    End date: 2006-06-05

Cyclophosphamide
    Dosage: 03jul2006-04sep2006: 750 mg i.v. 25sep2006-03okt2006: 775 mg i.v. 1 times infusion
    Start date: 2006-08-07
    End date: 2006-08-07

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-07-03
    End date: 2006-07-03

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-08-28
    End date: 2006-08-28

Mesna
    Dosage: 03jul2006-04sep2006: 200 mg i.v. 28sep2006-03okt2006: 230 mg i.v.
    Start date: 2006-07-10
    End date: 2006-07-10

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-09-25
    End date: 2006-09-25

Vincristine Sulfate
    Dosage: bolus injektion.
    Start date: 2006-09-04
    End date: 2006-09-04

Etoposide
    Indication: Hodgkin's Disease
    Start date: 2006-06-05
    End date: 2006-06-09

Other drugs received by patient: Potassium Chloride; Glucose ^sad^; Sodium Fluoride



Possible Mesna side effects in 17 year old female

Reported by a consumer/non-health professional from Denmark on 2012-03-30

Patient: 17 year old female

Reactions: Intervertebral Disc Protrusion, Back Pain, Lymphadenopathy, Pain in Extremity, Osteonecrosis, Fatigue, Pertussis, Arthralgia

Drug(s) suspected as cause:
Mesna
    Dosage: 3jul06-4sep06 200 mg iv; 25sep06-3oct06 230 mg 03, 10, 31jul; 07, 28aug and 03oct
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-03

Cyclophosphamide
    Dosage: 3jul06-4sep06 750 mg iv; 25sep06-3oct06 775 mg 1 hr infusion on 03, 10, 31jul; 07, 28aug and 03oct
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-03

Procarbazine Hydrochloride
    Dosage: natulanar
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-10

Oncovin
    Dosage: infusion dates 08,15,22may;5,12,19jun;03,10,31jul;07,28aug;04,11,25sep and 03oct.
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-03

Etoposide
    Dosage: given on may8,9,10,11,12 and jun5,6,7,8,9 2hr infusion
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-09

Adriamycin PFS
    Dosage: on 22may,5+19jun 4hr infusion
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-19

Prednisone TAB
    Dosage: 08may2006 to 03jul2006 35+25+25 mg 03jul2006 to 28aug2006 20 mg x 3
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-10

Other drugs received by patient: Dextrose; Natriumfluorid; Potassium Chloride



Possible Mesna side effects in female

Reported by a consumer/non-health professional from Denmark on 2012-03-30

Patient: female

Reactions: Intervertebral Disc Protrusion, Back Pain, Lymphadenopathy, Bone Pain, Pain, Fatigue, Osteonecrosis, Arthralgia, Pertussis

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 775 mg, qd
    Start date: 2006-09-25
    End date: 2006-10-03

Mesna
    Dosage: 200 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Prednisone TAB
    Dosage: 20 mg, tid
    Administration route: Oral
    Start date: 2006-08-29
    End date: 2006-10-10

Adriamycin PFS
    Dosage: 57.5 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-19

Etoposide
    Dosage: 180 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-09

Oncovin
    Dosage: 2 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-03

Prednisone TAB
    Dosage: 20 mg, tid
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-07-03

Prednisone TAB
    Dosage: 20 mg, tid
    Administration route: Oral
    Start date: 2006-07-03
    End date: 2006-08-28

Procarbazine Hydrochloride
    Dosage: 50 mg, tid
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-10

Cyclophosphamide
    Dosage: 750 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Mesna
    Dosage: 230 mg, unk
    Start date: 2006-09-25
    End date: 2006-10-03

Other drugs received by patient: Darrow-Glukose



Possible Mesna side effects in 17 year old female

Reported by a lawyer from Denmark on 2012-03-28

Patient: 17 year old female

Reactions: Back Pain, Intervertebral Disc Protrusion, Lymphadenopathy, Pain in Extremity, Fatigue, Osteonecrosis, Arthralgia, Pertussis

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: unk
    Administration route: Oral
    End date: 2006-10-10

Oncovin
    Dosage: 2 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-10-03

Adriamycin PFS
    Dosage: 57.5mg
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-19

Prednisone TAB
    Dosage: 20 mg, 3x/day
    Administration route: Oral
    Start date: 2006-07-03
    End date: 2006-08-28

Cyclophosphamide
    Dosage: 775 mg, unk
    Start date: 2006-09-25
    End date: 2006-10-03

Procarbazine Hydrochloride
    Dosage: 50 mg three times daily
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-10-10

Mesna
    Dosage: 230 mg, unk
    Start date: 2006-09-25
    End date: 2006-10-03

Etoposide
    Dosage: 180 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-06-09

Mesna
    Dosage: 200 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Prednisone TAB
    Dosage: 35 + 25 + 25 mg
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2006-05-08
    End date: 2006-07-03

Cyclophosphamide
    Dosage: 750 mg, unk
    Indication: Hodgkin's Disease
    Start date: 2006-07-03
    End date: 2006-09-04

Other drugs received by patient: Glucose ^sad^; Potassium Chloride; Natriumfluorid ^aco Lakemedel^



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient: 31 year old male

Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix



Possible Mesna side effects in male

Reported by a physician from United States on 2012-01-30

Patient: male

Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Neulasta
    Indication: Product Used FOR Unknown Indication

Leucovorin Calcium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Voriconazole; Fluconazole; Protonix; Valtrex; Medrol



Possible Mesna side effects in 50 year old male

Reported by a physician from Germany on 2012-01-27

Patient: 50 year old male

Reactions: Fatigue, Diarrhoea, Pancytopenia, Hyperhidrosis, Infection

Drug(s) suspected as cause:
Cyclophosphamide

Dexamethasone
    Dosage: 8 mg
    Indication: Evidence Based Treatment

Dacarbazine
    Indication: Thyroid Cancer

Vincristine

Dacarbazine

Cyclophosphamide

Granisetron
    Dosage: 3 mg
    Indication: Evidence Based Treatment

Mesna
    Dosage: 1200 mg

Cyclophosphamide
    Indication: Thyroid Cancer

Vincristine
    Indication: Thyroid Cancer

Vincristine

Dacarbazine



Possible Mesna side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-27

Patient: 61 year old female

Reactions: Vomiting, Fatigue, Nausea, Diarrhoea, Alopecia, Hyperhidrosis

Drug(s) suspected as cause:
Mesna

Cyclophosphamide
    Indication: Thyroid Cancer

Dexamethasone
    Indication: Evidence Based Treatment

Vincristine
    Indication: Thyroid Cancer

Dacarbazine
    Indication: Thyroid Cancer

Granisetron
    Indication: Evidence Based Treatment



Possible Mesna side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-27

Patient: 55 year old female

Reactions: Fatigue

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 8 mg
    Indication: Evidence Based Treatment

Dacarbazine
    Indication: Thyroid Cancer

Vincristine
    Indication: Thyroid Cancer

Mesna

Granisetron
    Dosage: 3 mg
    Indication: Evidence Based Treatment

Cyclophosphamide
    Indication: Thyroid Cancer



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-24

Patient: 31 year old male

Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mesna
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Methotrexate
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Vincristine Sulfate
    Indication: non-Hodgkin's Lymphoma

Pegfilgrastim
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Fluconazole; Voriconazole; Ciprofloxacin; Medrol; Pantoprazole; Valtrex



Possible Mesna side effects in male

Reported by a individual with unspecified qualification from United States on 2011-12-19

Patient: male

Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Mabthera

Cytarabine
    Dosage: 6.3 g, x4
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Dosage: 15 mg, q6h
    Administration route: Oral

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mesna
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 1680 mg, unk

Mabthera
    Dosage: 788 mg, unknown
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Medrol; Fluconazole; Protonix; Ciprofloxacin; Valtrex



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-19

Patient: 31 year old male

Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Protonix; Medrol; Voriconazole; Valtrex; Ciprofloxacin; Fluconazole



Possible Mesna side effects in male

Reported by a physician from United States on 2011-10-26

Patient: male, weighing 65.8 kg (144.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Vomiting, Nausea, Hypotension, Pyrexia, Headache, Hypokalaemia, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 24.775 g

Mesna
    Dosage: 24.75 g

Etoposide
    Dosage: 875 mg

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017